Literature DB >> 10028980

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group.

M J Wawer1, N K Sewankambo, D Serwadda, T C Quinn, L A Paxton, N Kiwanuka, F Wabwire-Mangen, C Li, T Lutalo, F Nalugoda, C A Gaydos, L H Moulton, M O Meehan, S Ahmed, R H Gray.   

Abstract

BACKGROUND: The study tested the hypothesis that community-level control of sexually transmitted disease (STD) would result in lower incidence of HIV-1 infection in comparison with control communities.
METHODS: This randomised, controlled, single-masked, community-based trial of intensive STD control, via home-based mass antibiotic treatment, took place in Rakai District, Uganda. Ten community clusters were randomly assigned to intervention or control groups. All consenting residents aged 15-59 years were enrolled; visited in the home every 10 months; interviewed; asked to provide biological samples for assessment of HIV-1 infection and STDs; and were provided with mass treatment (azithromycin, ciprofloxacin, metronidazole in the intervention group, vitamins/anthelmintic drug in the control). Intention-to-treat analyses used multivariate, paired, cluster-adjusted rate ratios.
FINDINGS: The baseline prevalence of HIV-1 infection was 15.9%. 6602 HIV-1-negative individuals were enrolled in the intervention group and 6124 in the control group. 75.0% of intervention-group and 72.6% of control-group participants provided at least one follow-up sample for HIV-1 testing. At enrolment, the two treatment groups were similar in STD prevalence rates. At 20-month follow-up, the prevalences of syphilis (352/6238 [5.6%]) vs 359/5284 [6.8%]; rate ratio 0.80 [95% CI 0.71-0.89]) and trichomoniasis (182/1968 [9.3%] vs 261/1815 [14.4%]; rate ratio 0.59 [0.38-0.91]) were significantly lower in the intervention group than in the control group. The incidence of HIV-1 infection was 1.5 per 100 person-years in both groups (rate ratio 0.97 [0.81-1.16]). In pregnant women, the follow-up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chlamydia infection were significantly lower in the intervention group than in the control group. No effect of the intervention on incidence of HIV-1 infection was observed in pregnant women or in stratified analyses.
INTERPRETATION: We observed no effect of the STD intervention on the incidence of HIV-1 infection. In the Rakai population, a substantial proportion of HIV-1 acquisition appears to occur independently of treatable STD cofactors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028980     DOI: 10.1016/s0140-6736(98)06439-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  219 in total

1.  Efforts to Control Sexually Transmitted Diseases As a Means to Limit HIV Transmission: Pros and Cons.

Authors:  Gina Dallabetta; Madaline Feinberg
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

Review 2.  Increasing prevalence of genital herpes in developing countries: implications for heterosexual HIV transmission and STI control programmes.

Authors:  N O'Farrell
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

3.  Mass or Syndromic Treatment of Sexually Transmitted Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

4.  HIV prevention research: accomplishments and challenges for the third decade of AIDS.

Authors:  J D Auerbach; T J Coates
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 5.  Reducing heterosexual transmission of HIV in poor countries.

Authors:  Peter R Lamptey
Journal:  BMJ       Date:  2002-01-26

Review 6.  Prevention of HIV among adolescents.

Authors:  M J Rotheram-Borus; Z O'Keefe; R Kracker; H H Foo
Journal:  Prev Sci       Date:  2000-03

Review 7.  An introduction to mathematical models in sexually transmitted disease epidemiology.

Authors:  G P Garnett
Journal:  Sex Transm Infect       Date:  2002-02       Impact factor: 3.519

Review 8.  Epidemiology and the politics of needle exchange.

Authors:  A R Moss
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

Review 9.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 10.  Criteria for detecting and understanding changes in the risk of HIV infection at a national level in generalised epidemics.

Authors:  G P Garnett; S Gregson; K A Stanecki
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.